Sickle Cell Anemia Therapeutics Market Size, Trends 2020 – Global Industry Share, Growth Analysis, Market Leaders, Business Demand, Application and Fastest CAGR During Forecast Period
Global Sickle Cell Anemia Therapeutics Market – Insights
Anemia is caused due to severe reduction of red blood cells (RBCs) or hemoglobin in the blood. The condition leads to low oxygen supply by blood. Sickle-cell disease (SCD) is a blood-related disorders. The condition is majorly inherited genetically. An individual may suffer from SCD when he/she inherits abnormal copies of hemoglobin gene from each parent. Sickle-cell anemia (SCA) is a common type of SCDs and is characterized by irregularity in hemoglobin and formation of a sickle-shaped cell. The disease is onset at an early age (within the first year of birth) and can give rise to pain attacks, also known as the sickle-cell crisis, swelling in the limbs, microbial infections, and in certain cases, stroke, and chronic pain may develop with age.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-sample/161
Global Sickle Cell Anemia Therapeutics Market: Drivers
High incidence of SCDs is expected to boost growth of the global sickle cell anemia therapeutics market over the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), as of 2016, around 100,000 people in the U.S. are affected by SCDs. The condition is very common among African Americans. Around 1 in 13 infants belonging to the race are born with the condition. Moreover, according to the National Center for Biotechnology Information, SCA is one of the most common hereditary hematological diseases among humans. Annually, around 250,000 children are born with the disease and it is among the most occurring epidemiological genetic diseases worldwide.
Increasing R&D in the treatment of SCA is also expected to boost growth of the global sickle cell anemia therapeutics market. For instance, in July 2019, in a study published in the journal ACS Sensors, researchers from Florida Atlantic University demonstrated a microfluidic impedance assay that can monitor the dynamic cell sickling and unsickling processes. The novel technology is expected to improve the monitoring of SCA.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/161
Increasing government initiatives for prevention and treatment of SCA is also expected to boost growth of the market. Moreover, increasing demand for early detection and prevention of curable diseases especially among the adults is expected to offer lucrative growth opportunities for the market players.
Global Sickle Cell Anemia Therapeutics Market: Restraints
However, negative results in clinical trials for the treatment of SCA are expected to hamper growth of the global sickle cell anemia therapeutics market. For instance, in August 2019, Pfizer Inc. announced that the Phase III Rivipansel pivotal study to evaluate the efficacy and safety of rivipansel in patients aged six and older with sickle cell disease failed to achieve its primary or key secondary efficacy endpoints.
Global Sickle Cell Anemia Therapeutics Market: Taxonomy
On the basis of type of medication, the global sickle cell anemia therapeutics market is classified into:
-
- Antibiotics
- Pain-relieving medications
- Hydroxyurea
- Others
On the basis of end-user, the global sickle cell anemia therapeutics market is classified into:
-
- Government
- Hospitals
- Private Clinics
- Others
On the basis of region, the global sickle cell anemia therapeutics market is classified into:
-
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/sickle-cell-anemia-therapeutics-market-161
Global Sickle Cell Anemia Therapeutics Market: Regional Analysis
Africa is expected to witness significant growth in the global sickle cell anemia therapeutics market, owing to increasing prevalence of SCA in the region. For instance, according to the World Health Organization, around 5% of the population around the globe carries the gene for the sickle cell disease. This percentage is as high as 25% in some of the regions around the world and the occurrence of the condition is the highest in Africa. Moreover, according to PLOS Medicine, the prevalence of SCA is expected to increase by around 30% by 2050, especially in the sub-Saharan Africa.
Global Sickle Cell Anemia Therapeutics Market: Competitive Landscape
Major players in the market are focused on launching platform to screen drugs for the treatment of SCA. For instance, in August 2019, ReachBio Research Labs started offering a drug screening platform to assess fetal hemoglobin protein induction in drug candidates for the treatment of SCA.
Major players operating in the global sickle cell anemia therapeutics market include Pfizer, Anthera Pharmaceuticals Inc., Daiichi Sankyo, Novartis Pharmaceuticals, Mast Therapeutics, HemaQuest Pharmaceuticals Inc., Bluebird Bio, Bristol-Myers Squibb, GlycoMimetics, GlycoMimetics, Inc., Eli Lilly, Emmaus Medical, HemaQuest Pharmaceuticals, Baxter, and Merck Sharp & Dohme.
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- PEST Analysis
- Market Dynamics
- Global Sickle Cell Anemia Therapeutics – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Safety Syringes for COIVD-19 Vaccines
- Global Sickle Cell Anemia Therapeutics Market, By Product Type, 2016 – 2027, (US$ Mn)
- Global Sickle Cell Anemia Therapeutics Market, By Application, 2016 – 2027, (US$ Mn)
- Global Sickle Cell Anemia Therapeutics Market, By End User, 2016 – 2027, (US$ Mn)
- Global Sickle Cell Anemia Therapeutics Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
